15 December 1996 | Volume 125 Issue 12 | Pages 955-960
Background: It has been reported that women with an inherited deficiency of antithrombin, protein C, or protein S have an increased risk for developing venous thromboembolic disease during pregnancy and the postpartum period. However, because the available data on risk are flawed, it is difficult to define a rational, efficacious, and safe policy about prophylaxis for venous thromboembolism in these women.
Objective: To determine the frequency of venous thromboembolism during pregnancy and the postpartum period in women with heritable deficiencies of anticoagulant factors.
Design: Retrospective cohort study.
Setting: University outpatient clinics in the Netherlands and Italy.
Participants: 129 otherwise asymptomatic female family members of patients with a history of venous thromboembolism and an established deficiency of antithrombin, protein C, or protein S.
Measurements: Medical history, with specific attention to episodes of venous thromboembolism and obstetric history, was taken. The anticoagulant factor status of the study participants was determined. If a patient had an episode of venous thromboembolism, subsequent pregnancies in that patient were not analyzed.
Results: Of the 129 women who participated in the study, 60 had anticoagulant factor deficiency and 69 did not. In the nondeficient group, 198 pregnancies occurred; 1 of these (0.5%) was complicated by an episode of venous thromboembolism during the postpartum period. In the deficient group, 169 pregnancies occurred; 7 of these (4.1%) were complicated by an episode of venous thromboembolism during the third trimester of pregnancy (2 pregnancies [1.2%]) and the postpartum period (5 pregnancies [3.0%]). The risk for venous thromboembolism was increased eightfold in deficient women compared with nondeficient women (hazard ratio, 8.0 [95% CI, 1.2 to 184]).
Conclusions: Anticoagulant factor-deficient women have an increased risk for venous thromboembolism during pregnancy and the postpartum period. Although data from an appropriate randomized clinical trial are lacking, the frequency of venous thromboembolism seen in deficient women might justify the use of anticoagulative prophylaxis during the third trimester of pregnancy and the postpartum period.
ARTICLE
Frequency of Pregnancy-Related Venous Thromboembolism in Anticoagulant Factor-Deficient Women: Implications for Prophylaxis
Related articles in Annals:
This article has been cited by other articles:
![]() |
S. M. Bates, I. A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 844S - 886S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Merriman and M Greaves Testing for thrombophilia: an evidence-based approach Postgrad. Med. J., November 1, 2006; 82(973): 699 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Quinones, D. N. James, D. M. Stamilio, K. L. Cleary, and G. A. Macones Thromboprophylaxis After Cesarean Delivery: A Decision Analysis Obstet. Gynecol., October 1, 2005; 106(4): 733 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bates, I. A. Greer, J. Hirsh, and J. S. Ginsberg Use of Antithrombotic Agents During Pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 627S - 644S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Sartori, C. Danesin, G. Saggiorato, D. Tormene, P. Simioni, L. Spiezia, G. M. Patrassi, and A. Girolami The PAI-I gene 4G/5G Polymorphism and Deep Vein Thrombosis in Patients with Inherited Thrombophilia Clinical and Applied Thrombosis/Hemostasis, October 1, 2003; 9(4): 299 - 307. [Abstract] [PDF] |
||||
![]() |
S. R Deitcher and M. P. Gomes Hypercoagulable state testing and malignancy screening following venous thromboembolic events Vascular Medicine, February 1, 2003; 8(1): 33 - 46. [Abstract] [PDF] |
||||
![]() |
S. M. Bates and J. S. Ginsberg How we manage venous thromboembolism during pregnancy Blood, November 15, 2002; 100(10): 3470 - 3478. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kalafatis, P. Simioni, D. Tormene, D. O. Beck, S. Luni, and A. Girolami Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations Blood, May 13, 2002; 99(11): 3985 - 3992. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Bauer The Thrombophilias: Well-Defined Risk Factors with Uncertain Therapeutic Implications Ann Intern Med, September 4, 2001; 135(5): 367 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Seligsohn and A. Lubetsky Genetic Susceptibility to Venous Thrombosis N. Engl. J. Med., April 19, 2001; 344(16): 1222 - 1231. [Full Text] [PDF] |
||||
![]() |
M. T. Sartori, P. Simioni, G. M. Patrassi, P. Theodoridis, D. Tormene, and A. Girolami State-of-the-Art-Review : Combined Heterozygous Plasminogen Deficiency and Factor V Leiden Defect in the Same Kindred Clinical and Applied Thrombosis/Hemostasis, January 1, 2000; 6(1): 36 - 40. [Abstract] [PDF] |
||||
![]() |
B.-J. Sanson, P. Simioni, D. Tormene, M. Moia, P. W. Friederich, M. V. Huisman, P. Prandoni, A. Bura, L. Rejto, P. Wells, et al. The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study Blood, December 1, 1999; 94(11): 3702 - 3706. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Sartori, G. M. Patrassi, P. Theodoridis, C. Danesin, C. Abati, and A. Girolami Familial Association of Hypoplasminogenemia and Heterozygous Factor V Deficiency Clinical and Applied Thrombosis/Hemostasis, October 1, 1999; 5(4): 277 - 281. [Abstract] [PDF] |
||||
![]() |
M. de Swiet Review Article: Management of pulmonary embolus in pregnancy Eur. Heart J., October 1, 1999; 20(19): 1378 - 1385. [PDF] |
||||
![]() |
Pregnancy, Anticoagulant Deficiency, and Thromboembolic Risk Journal Watch Women's Health, February 1, 1997; 1997(201): 17 - 17. [Full Text] |
||||